Regional Cerebral Hemodynamics Related to Global Hemodynamics

November 25, 2013 updated by: Dorothea Closhen, Johannes Gutenberg University Mainz

Impact of Systemic Hemodynamic Changes on Cerebral Perfusion and Oxygenation

This prospective investigation studies changes in regional cerebral hemodynamics and oxygenation as a function of cardiac output and blood pressure in intensive care patients.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Cerebral blood flow velocity (as an index of regional perfusion), dynamic cerebral autoregulation and regional cerebral oxygen saturation should be monitored if disturbances of cerebral perfusion and oxygenation have to be suspected. Noninvasive monitoring techniques are established. When detected early, disturbed perfusion and oxygenation may be treated promptly and permanent damage of brain tissue can be avoided.

In critically ill patients, hemodynamic changes occur due to the disease itself but also as a function of diagnostic and therapeutic procedures. Systemic hemodynamic changes can be monitored using PiCCO® system (pulse contour cardiac output, Pulsion Medical Systems, Munich, Germany) that combines transpulmonal thermodilution and pulse contour analysis. PiCCO® continuously monitors cardiac output (CO), as well as static parameters like global enddiastolic blood volume index (GEDVI), and dynamic parameters as difference in pulse pressure (dPP) and stroke volume variation (SVV), respectively. CC Nexfin® (BMeye, Amsterdam, The Netherlands) is a noninvasive hemodynamic monitor.

This study investigates the effects of changes in cardiac output on cerebral blood flow velocity and regional cerebral oxygen saturation in intensive care patients that underwent major abdominal surgery.

Study Type

Observational

Enrollment (Anticipated)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mainz, Germany, 55131
        • Recruiting
        • Johannes Gutenberg University Mainz
        • Contact:
        • Principal Investigator:
          • Dorothea Closhen, MD
        • Sub-Investigator:
          • Guntehr Pestel, MD, PhD
        • Sub-Investigator:
          • Matthias David, MD, PhD
        • Sub-Investigator:
          • Kimiko Fukui, MD, PhD
        • Sub-Investigator:
          • Patrick Schramm, MD
        • Sub-Investigator:
          • Larissa Philippi, MD
        • Sub-Investigator:
          • Lydia Strys, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

critically ill patients mechanically ventilated patients

Description

Inclusion Criteria:

  • critically ill
  • mechanically ventilated
  • needing advanced hemodynamic monitoring (PiCCO)

Exclusion Criteria:

  • <18years
  • > 80years
  • rhythm other than sinus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
cerebral blood flow velocity
Time Frame: 1 hour
1 hour

Secondary Outcome Measures

Outcome Measure
Time Frame
Cerebral oxygen saturation
Time Frame: 1 hour
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

November 20, 2013

First Submitted That Met QC Criteria

November 25, 2013

First Posted (Estimate)

November 26, 2013

Study Record Updates

Last Update Posted (Estimate)

November 26, 2013

Last Update Submitted That Met QC Criteria

November 25, 2013

Last Verified

July 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • CLS_002
  • 837.437.11(7979) (Other Identifier: Ethics Commitee of Rhineland Palatinate)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill Patients

Clinical Trials on PLR

3
Subscribe